All Title Author
Keywords Abstract

PLOS ONE  2012 

Cardiovascular Responses to Chemical Stimulation of the Hypothalamic Arcuate Nucleus in the Rat: Role of the Hypothalamic Paraventricular Nucleus

DOI: 10.1371/journal.pone.0045180

Full-Text   Cite this paper   Add to My Lib

Abstract:

The mechanism of cardiovascular responses to chemical stimulation of the hypothalamic arcuate nucleus (ARCN) was studied in urethane-anesthetized adult male Wistar rats. At the baseline mean arterial pressure (BLMAP) close to normal, ARCN stimulation elicited decreases in MAP and sympathetic nerve activity (SNA). The decreases in MAP elicited by ARCN stimulation were attenuated by either gamma-aminobutyric acid (GABA), neuropeptide Y (NPY), or beta-endorphin receptor blockade in the ipsilateral hypothalamic paraventricular nucleus (PVN). Combined blockade of GABA-A, NPY1 and opioid receptors in the ipsilateral PVN converted the decreases in MAP and SNA to increases in these variables. Conversion of inhibitory effects on the MAP and SNA to excitatory effects following ARCN stimulation was also observed when the BLMAP was decreased to below normal levels by an infusion of sodium nitroprusside. The pressor and tachycardic responses to ARCN stimulation at below normal BLMAP were attenuated by blockade of melanocortin 3/4 (MC3/4) receptors in the ipsilateral PVN. Unilateral blockade of GABA-A receptors in the ARCN increased the BLMAP and heart rate (HR) revealing tonic inhibition of the excitatory neurons in the ARCN. ARCN stimulation elicited tachycardia regardless of the level of BLMAP. ARCN neurons projecting to the PVN were immunoreactive for glutamic acid decarboxylase 67 (GAD67), NPY, and beta-endorphin. These results indicated that: 1) at normal BLMAP, decreases in MAP and SNA induced by ARCN stimulation were mediated via GABA-A, NPY1 and opioid receptors in the PVN, 2) lowering of BLMAP converted decreases in MAP following ARCN stimulation to increases in MAP, and 3) at below normal BLMAP, increases in MAP and HR induced by ARCN stimulation were mediated via MC3/4 receptors in the PVN. These results provide a base for future studies to explore the role of ARCN in cardiovascular diseases.

References

[1]  Ghamari-Langroudi M (2012) Electrophysiological analysis of circuits controlling energy homeostasis. Mol Neurobiol 45: 258–278.
[2]  Meister B (2007) Neurotransmitters in key neurons of the hypothalamus that regulate feeding behavior and body weight. Physiol Behav 92: 263–271.
[3]  Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW (2006) Central nervous system control of food intake and body weight. Nature 443: 289–295.
[4]  Sanchez-Lasheras C, Konner AC, Bruning JC (2010) Integrative neurobiology of energy homeostasis-neurocircuits, signals and mediators. Front Neuroendocrinol 31: 4–15.
[5]  Schwartz MW, Woods SC, Porte JD Jr, Seeley RJ, Baskin DG (2000) Central nervous system control of food intake. Nature 404: 661–671.
[6]  Belgardt BF, Okamura T, Bruning JC (2009) Hormone and glucose signalling in POMC and AgRP neurons. J Physiol 587: 5305–5314.
[7]  Chronwall BM (1985) Anatomy and physiology of the neuroendocrine arcuate nucleus. Peptides 6 Suppl 21–11.
[8]  Ovesjo ML, Gamstedt M, Collin M, Meister B (2001) GABAergic nature of hypothalamic leptin target neurones in the ventromedial arcuate nucleus. J Neuroendocrinol 13: 505–516.
[9]  Horvath TL, Bechmann I, Naftolin F, Kalra SP, Leranth C (1997) Heterogeneity in the neuropeptide Y-containing neurons of the rat arcuate nucleus: GABAergic and non-GABAergic subpopulations. Brain Res 756: 283–286.
[10]  Pritchard LE, Turnbull AV, White A (2002) Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signaling and obesity. J Endocrinol 172: 411–421.
[11]  Ibata Y, Kawakami F, Okamura H, Obata-Tsuto HL, Morimoto N, et al. (1985) Light and electron microscopic immunocytochemistry of beta-endorphin/beta-LPH-like immunoreactive neurons in the arcuate nucleus and surrounding areas of the rat hypothalamus. Brain Res 341: 233–242.
[12]  Lantos TA, Gorcs TJ, Palkovits M (1995) Immunohistochemical mapping of neuropeptides in the premamillary region of the hypothalamus in rats. Brain Res Rev 20: 209–249.
[13]  Dicken MS, Tooker RE, Hentges ST (2012) Regulation of GABA and glutamate release from proopiomelanocortin neuron terminals in intact hypothalamic networks. J Neurosci 32: 4042–4048.
[14]  Hentges ST, Otero-Corchon V, Pennock RL, King CM, Low MJ (2009) Proopiomelanocortin expression in both GABA and glutamate neurons. J Neurosci 29: 13684–13690.
[15]  Dampney RA (2011) Arcuate nucleus - a gateway for insulin’s action on sympathetic activity. J Physiol 589: 2109–2110.
[16]  Rahmouni K, Morgan DA (2007) Hypothalamic arcuate nucleus mediates the sympathetic and arterial pressure responses to leptin. Hypertension 49: 647–652.
[17]  Coote JH (2004) The hypothalamus and cardiovascular regulation. In: Dun NJ, Machado BH, Pilowsky PM, editors. Neural Mechanisms of Cardiovascular Regulation. Boston, MA, USA: Kluwer Academic Publishers. 117–146.
[18]  Kawabe T, Chitravanshi VC, Kawabe K, Sapru HN (2008) Cardiovascular function of a glutamatergic projection from the hypothalamic paraventricular nucleus to the nucleus tractus solitarius in the rat. Neuroscience 153: 605–617.
[19]  Chen QH, Haywood JR, Toney GM (2003) Sympathoexcitation by PVN-injected bicuculline requires activation of excitatory amino acid receptors. Hypertension 42: 725–731.
[20]  Kannan H, Niijima A, Yamashita H (1988) Effects of stimulation of the hypothalamic paraventricular nucleus on blood pressure and renal sympathetic nerve activity. Brain Res Bull 20: 779–783.
[21]  Li YF, Jackson KL, Stern JE, Rabeler B, Patel KP (2006) Interaction between glutamate and GABA systems in the integration of sympathetic outflow by the paraventricular nucleus of hypothalamus. Am J Physiol Heart Circ Physiol 291: H2847–2856.
[22]  Holstege G (1987) Some anatomical observations on the projections from the hypothalamus to brainstem and spinal cord: an HRP and autoradiographic tracing study in the cat. J Comp Neurol 260: 98–126.
[23]  Pyner S, Coote JH (1999) Identification of an efferent projection from the paraventricular nucleus of the hypothalamus terminating close to spinally projecting rostral ventrolateral medullary neurons. Neuroscience 88: 949–957.
[24]  Pyner S, Coote JH (2000) Identification of branching paraventricular neurons of the hypothalamus that project to the rostroventrolateral medulla and spinal cord. Neuroscience 100: 549–556.
[25]  Yang Z, Coote JH (1998) Influence of the hypothalamic paraventricular nucleus on cardiovascular neurons in the rostral ventrolateral medulla of the rat. J Physiol 513: 521–530.
[26]  Yang Z, Wheatley M, Coote JH (2002) Neuropeptides, amines and amino acids as mediators of the sympathetic effects of paraventricular nucleus activation in the rat. Exp Physiol 87: 663–674.
[27]  Yang Z, Bertram D, Coote JH (2001) The role of glutamate and vasopressin in the excitation of RVL neurones by paraventricular neurones. Brain Res 908: 99–103.
[28]  Arakawa H, Chitravanshi VC, Sapru HN (2011) The hypothalamic arcuate nucleus: a new site of cardiovascular action of angiotensin-(1–12) and angiotensin II. Am J Physiol Heart Circ Physiol 300: H951–H960.
[29]  Nakamura T, Bhatt S, Sapru HN (2009) Cardiovascular responses to hypothalamic arcuate nucleus stimulation in the rat: role of sympathetic and vagal efferents. Hypertension 54: 1369–1375.
[30]  Kow LM, Pfaff DW (1989) Responses of hypothalamic paraventricular neurons in vitro to norepinephrine and other feeding-relevant agents. Physiol Behav 46: 265–271, 1989.
[31]  Pennock RL, Hentges ST (2011) Differential expression and sensitivity of presynaptic and postsynaptic opioid receptors regulating hypothalamic proopiomelanocortin neurons. J Neurosci 31: 281–288.
[32]  Albers HE, Ottenweller JE, Liou SY, Lumpkin MD, Anderson ER (1990) Neuropeptide Y in the hypothalamus: effect on corticosterone and single-unit activity. Am J Physiol Regul Integr Comp Physiol 258: R376–R382.
[33]  Badoer E (2001) Hypothalamic paraventricular nucleus and cardiovascular regulation. Clin Exp Pharmacol Physiol 28: 95–99.
[34]  Dampney RA, Horiuchi J, Killinger S, Sheriff MJ, Tan PS, et al. (2005) Long-term regulation of arterial blood pressure by hypothalamic nuclei: some critical questions. Clin Exp Pharmacol Physiol 32: 419–425.
[35]  Stern J (2004) Cellular properties of autonomic-related neurons in the paraventricular nucleus of the hypothalamus. In: Dun NJ, Machado BH, Pilowsky PM, editors. Neural Mechanisms of Cardiovascular Regulation. Boston, MA, USA: Kluwer Academic Publishers. 147–161.
[36]  Kawabe T, Chitravanshi VC, Kawabe K, Sapru HN (2006) Cardiovascular effects of adrenocorticotropin microinjections into the rostral ventrolateral medullary pressor area of the rat. Brain Res 1102: 117–126.
[37]  Paxinos G, Watson C (2007) The Rat Brain in Stereotaxic Coordinates. 6th ed. London: Academic Press.
[38]  Kasamatsu K, Chitravanshi VC, Sapru HN (2004) Depressor and bradycardic responses to microinjections of endomorphin-2 into the NTS are mediated via ionotropic glutamate receptors. Am J Physiol Regul Integr Comp Physiol 287: R715–R728.
[39]  Taylor K, Lester E, Hudson B, Ritter S (2007) Hypothalamic and hindbrain NPY, AGRP and NE increase consummatory feeding responses. Physiol Behav 90: 744–750.
[40]  Mao L, Wang JQ (2005) Cardiovascular responses to microinjection of nociceptin and endomorphin-1 into the nucleus tractus solitarii in conscious rats. Neuroscience 132: 1009–1015.
[41]  Li SJ, Varga K, Archer P, Hruby VJ, Sharma SD, et al. (1996) Melanocortin antagonists define two distinct pathways of cardiovascular control by alpha- and gamma-melanocyte-stimulating hormones. J Neurosci 16: 5182–5188.
[42]  Viard E, Sapru HN (2006) Endomorphin-2 in the medial NTS attenuates the responses to baroreflex activation. Brain Res 1073–1074: 365–373.
[43]  Antal-Zimanyi I, Bruce MA, Leboulluec KL, Iben LG, Mattson GK, et al. (2008) Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist. Eur J Pharmacol 590: 224–232.
[44]  Biebermann H, Kuhnen P, Kleinau G, Krude H (2012) The neuroendocrine circuitry controlled by POMC, MSH, and AGRP. Handb Exp Pharmacol 209: 47–75.
[45]  Ye ZY, Li DP (2011) Activation of the melanocortin-4 receptor causes enhanced excitation in presympathetic paraventricular neurons in obese Zucker rats. Regul Pept 166: 112–120.
[46]  Dun SL, Brailoiu GC, Yang J, Chang JK, Dun NJ (2006) Cocaine- and amphetamine-regulated transcript peptide and sympatho-adrenal axis. Peptides 27: 1949–1955.
[47]  Guyenet PG (2006) The sympathetic control of blood pressure. Nature Rev Neurosci 7: 335–346.
[48]  Sapru HN (2002) Glutamate circuits in selected medullo-spinal areas regulating cardiovascular function. Clin Exp Pharmacol Physiol 29: 491–496.
[49]  Mendelowitz D (1999) Advances in Parasympathetic Control of Heart Rate and Cardiac Function. News Physiol Sci 14: 155–161.
[50]  Martin DS, Haywood JR (1993) Hemodynamic responses to paraventricular nucleus disinhibition with bicuculline in conscious rats. Am J Physiol Heart Circ Physiol 265: H1727–H1733.
[51]  Nicholson C (1985) Diffusion from an injected volume of a substance in brain tissue with arbitrary volume fraction and tortuosity. Brain Res 333: 325–329.
[52]  Li C, Chen P, Smith MS (1998) Neuropeptide Y (NPY) neurons in the arcuate nucleus (ARH) and dorsomedial nucleus (DMH), areas activated during lactation, project to the paraventricular nucleus of the hypothalamus (PVH). Regul Pept 75–76: 93–100.
[53]  Gross PM (1992) Circumventricular organ capillaries. Prog Brain Res 91: 219–233.
[54]  Ciofi P, Garret M, Lapirot O, Lafon P, Loyens A, et al. (2009) Brain-endocrine interactions: a microvascular route in the mediobasal hypothalamus. Endocrinology 150: 5509–5519.

Full-Text

comments powered by Disqus